EW - Edwards Lifesciences Corp

$86.39 +0.00 (+0.00%)

Pre-Market: $86.39 +0.00 (+0.00%)

Last updated: Oct 13, 2026 08:04

52-Week Range

$86.39

$72.30 $86.39 $96.29

Fundamentals Overview

Edwards Lifesciences Corp is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 49.1 PEG 3.36 P/B 4.91 P/S 7.57

Profitability

ROE 9.69% Net margin 15.4%

Risk (Beta)

0.83 — in line vol

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Sell — 66% confidence Risk: Moderate Volatility — Beta 0.83. Diversify and only invest what you can afford to lose.

Pressures (Sell):

P/E 49.1 (premium) · PEG 3.36

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$49.80B

P/E (TTM)

49.06

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$72.30 - $96.29

Volume vs Avg

N/A

Beta

0.83

About

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Sector: Healthcare

Headquarters: US

Website: www.edwards.com

Beta: 0.83 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	49.06
PEG (TTM)	3.36
P/B (TTM)	4.91
P/S (TTM)	7.57
Profitability
ROE (TTM)	9.69%
ROA (TTM)	7.42%
Revenue growth (YoY)	N/A
Net margin (TTM)	15.43%
Gross margin (TTM)	77.84%
Operating margin (TTM)	18.21%
Debt to equity (TTM)	0.06

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for EW.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.